These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 29032851

  • 21. A case of in-stent thrombosis in a patient with drug eluting stents during perioperative management with glycoprotein IIb/IIIa inhibitors.
    Singh M, Bolla VH, Berg R.
    Catheter Cardiovasc Interv; 2013 Dec 01; 82(7):1108-12. PubMed ID: 23378243
    [Abstract] [Full Text] [Related]

  • 22. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R, Kirtane AJ, Torguson R, Cohen DJ, Ryan T, Räber L, Applegate R, Waxman S, Gordon P, Kaneshige K, Leon MB, DESERT Investigators.
    JACC Cardiovasc Interv; 2014 Oct 01; 7(10):1093-102. PubMed ID: 25240540
    [Abstract] [Full Text] [Related]

  • 23. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V, Cuisset T, Chenu P, Vrolix M, Martinez C, Dens J, Gach O, Boland J, Claeys MJ, Magne J, Barbato E, Wijns W.
    EuroIntervention; 2014 Jun 01; 10(2):204-11. PubMed ID: 24952058
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M, Tebaldi M, Borghesi M, Vranckx P, Campo G, Tumscitz C, Cangiano E, Minarelli M, Scalone A, Cavazza C, Marchesini J, Parrinello G, PRODIGY Investigators.
    JACC Cardiovasc Interv; 2014 Jan 01; 7(1):20-8. PubMed ID: 24332420
    [Abstract] [Full Text] [Related]

  • 26. ISAR-REACT 5 - What have we learned?
    Kubica J, Jaguszewski M.
    Cardiol J; 2019 Jan 01; 26(5):427-428. PubMed ID: 31536136
    [No Abstract] [Full Text] [Related]

  • 27. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL, Ye F, Zhang JJ, Zou JJ, Qian XS, Li F, Yang S, Ge Z, Shan SJ, Li XB, Xu T, Kan J, Lin L, Han YL.
    Cardiovasc Ther; 2013 Aug 01; 31(4):193-200. PubMed ID: 22954234
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Everolimus-eluting bioresorbable scaffold implantation for the treatment of bifurcation lesions - Implications from early clinical experience during daily practice.
    Wiebe J, Dörr O, Bauer T, Liebetrau C, Boeder N, Möllmann H, Hamm CW, Nef HM.
    Cardiovasc Revasc Med; 2016 Aug 01; 17(5):313-7. PubMed ID: 27085220
    [Abstract] [Full Text] [Related]

  • 32. Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice.
    Cho MS, Park DW.
    Korean J Intern Med; 2017 Sep 01; 32(5):769-779. PubMed ID: 28823143
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Drug-eluting stents: boom or bust?
    Laskey WK.
    Ann Intern Med; 2014 Nov 18; 161(10):740-1. PubMed ID: 25402515
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials.
    Verdoia M, Schaffer A, Barbieri L, Montalescot G, Collet JP, Colombo A, Suryapranata H, De Luca G.
    Angiology; 2016 Mar 18; 67(3):224-38. PubMed ID: 26069031
    [Abstract] [Full Text] [Related]

  • 40. Duration of dual antiplatelet therapy after implantation of the first-generation and second-generation drug-eluting stents.
    Yu X, Chen F, He J, Gao Y, Wu C, Luo Y, Zhang X, Zhang Y, Ren X, Lv S.
    Coron Artery Dis; 2013 May 18; 24(3):217-23. PubMed ID: 23425771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.